InsidersTradesSigma
Total declarations
Company
▲ Purchases (44 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Peyer James, Board Member. Officer active across 1 companies, notably Sensei Biotherapeutics, Inc.. Cumulatively, 45 filings have been published. Total volume traded: €2.3m. The latest transaction was disclosed on 10 June 2022 — Attribution. Regulator: SEC (Form 4). All data is free.
Declarations45 total
04,466 shares0
Restricted Stock Unit Grant
SEC:0001567619-22-012841:0·
€3,4581,203 shares@ €2.87440.013% mcap0.1% of flow
Common Stock
SEC:0001567619-22-012647:0·
Ideal exit: 27 Nov 2022 (T+270)
€12,327752 shares@ €16.39280.045% mcap0.5% of flow
Common Stock
SEC:0001567619-22-008802:0·
Ideal exit: 15 Nov 2021 (T+270)
€114,1629,500 shares@ €12.01710.42% mcap4.9% of flow
Common Stock
SEC:0001567619-22-008804:0·
Ideal exit: 18 Dec 2021 (T+270)
€3,4581,203 shares@ €2.87440.013% mcap0.1% of flow
Common Stock
SEC:0001567619-22-006006:0·
Ideal exit: 27 Nov 2022 (T+270)
€13542 shares@ €3.21970.0005% mcap0.0% of flow
Common Stock
SEC:0001567619-22-005915:0·
Ideal exit: 25 Nov 2022 (T+270)
€8,1542,500 shares@ €3.26160.030% mcap0.4% of flow
Common Stock
SEC:0001567619-22-005792:0·
Ideal exit: 22 Nov 2022 (T+270)
€8,3852,500 shares@ €3.35420.031% mcap0.4% of flow
Common Stock
SEC:0001567619-22-005517:0·
Ideal exit: 20 Nov 2022 (T+270)
€18,1424,949 shares@ €3.66580.066% mcap0.8% of flow
Common Stock
SEC:0001567619-22-005191:0·
Ideal exit: 14 Nov 2022 (T+270)
€36,77910,000 shares@ €3.67790.13% mcap1.6% of flow
Common Stock
SEC:0001567619-22-004777:0·
Ideal exit: 11 Nov 2022 (T+270)
€20,0505,000 shares@ €4.010.073% mcap0.9% of flow
Common Stock
SEC:0001567619-22-004545:0·
Ideal exit: 7 Nov 2022 (T+270)
€72,01417,500 shares@ €4.11510.26% mcap6.9% of flow
Common Stock
SEC:0001567619-22-002935·
Ideal exit: 31 Oct 2022 (T+270)
€72,01417,500 shares@ €4.11510.26% mcap3.1% of flow
Common Stock
SEC:0001567619-22-002935:0·
Ideal exit: 31 Oct 2022 (T+270)
€23,3836,100 shares@ €3.83330.085% mcap1.0% of flow
Common Stock
SEC:0001567619-22-002034:0·
Ideal exit: 24 Oct 2022 (T+270)
€23,3836,100 shares@ €3.83330.085% mcap2.2% of flow
Common Stock
SEC:0001567619-22-002034·
Ideal exit: 24 Oct 2022 (T+270)
€86,26420,100 shares@ €4.29170.31% mcap8.3% of flow
Common Stock
SEC:0001567619-22-001804·
Ideal exit: 22 Oct 2022 (T+270)
€86,26420,100 shares@ €4.29170.31% mcap3.7% of flow
Common Stock
SEC:0001567619-22-001804:0·
Ideal exit: 22 Oct 2022 (T+270)
€107,86224,703 shares@ €4.36640.39% mcap10.3% of flow
Common Stock
SEC:0001567619-22-001634·
Ideal exit: 18 Oct 2022 (T+270)
€107,86224,703 shares@ €4.36640.39% mcap4.7% of flow
Common Stock
SEC:0001567619-22-001634:0·
Ideal exit: 18 Oct 2022 (T+270)
€44,93810,244 shares@ €4.38670.16% mcap4.3% of flow
Common Stock
SEC:0001567619-22-001464·
Ideal exit: 16 Oct 2022 (T+270)
€44,93810,244 shares@ €4.38670.16% mcap1.9% of flow
Common Stock
SEC:0001567619-22-001464:0·
Ideal exit: 16 Oct 2022 (T+270)
€44,52010,000 shares@ €4.4520.16% mcap4.3% of flow
Common Stock
SEC:0001567619-22-001342·
Ideal exit: 15 Oct 2022 (T+270)
€44,52010,000 shares@ €4.4520.16% mcap1.9% of flow
Common Stock
SEC:0001567619-22-001342:0·
Ideal exit: 15 Oct 2022 (T+270)
€89,46219,953 shares@ €4.48360.33% mcap8.6% of flow
Common Stock
SEC:0001567619-22-001230·
Ideal exit: 10 Oct 2022 (T+270)
€89,46219,953 shares@ €4.48360.33% mcap3.9% of flow
Common Stock
SEC:0001567619-22-001230:0·
Ideal exit: 10 Oct 2022 (T+270)
25 of 45 declarations
About Peyer James
James Peyer is a Board Member at Sensei Biotherapeutics, Inc.
